COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a One-Time antibody infusion stop COVID-19 from getting worse?
Disease control Recruiting nowThis study tests whether a single infusion of concentrated antibodies against COVID-19 can help adults with early, mild COVID-19 avoid severe illness. About 820 participants aged 55+ or with weakened immune systems will receive either the antibody treatment or a placebo. The goal…
Matched conditions: COVID
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New At-Home COVID test put to the test in 1,000-Person study
Diagnosis Recruiting nowThis study checks if a new COVID-19 test (Metrix COVID Test) works well when used at home or in clinics. About 1,000 people with COVID-like symptoms will take the test, and results will be compared to a standard FDA-cleared test. The goal is to see if the new test accurately dete…
Matched conditions: COVID
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated May 26, 2026 08:39 UTC
-
New test aims to spot coronaviruses faster and more accurately
Diagnosis Recruiting nowThis study evaluates a new test called the BioFire Emerging Coronavirus Panel, which looks for coronaviruses in nose swab samples. Researchers will check how well the test detects these viruses compared to standard methods. About 1,500 leftover swab samples from routine care will…
Matched conditions: COVID
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated May 26, 2026 08:39 UTC
-
AI helps cancer patients find the right clinical trial
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence tool can help match cancer patients to clinical trials they might be eligible for. Researchers will enroll up to 50,000 people with various types of cancer and use the AI to suggest trials. The goal is to see if this approa…
Matched conditions: COVID
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC